ESR1 and breast carcinoma: Triple negative Breast Cancer (TNBC) is a histological subtype of breast cancer (BC) characterized by the immunohistochemical lack of expression (< 1%) of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2).